Recurrence of a 30-years old leukemic clone ten years after allogeneic transplant: Azacitidine and donor lymphocyte infusion are an effective strategy to restore the graft-versus leukemia effect

MLA

Iovino L, et al. “Recurrence of a 30-Years Old Leukemic Clone Ten Years after Allogeneic Transplant: Azacitidine and Donor Lymphocyte Infusion Are an Effective Strategy to Restore the Graft-versus Leukemia Effect.” Journal of Translational Science, vol. 5, Jan. 2018. EBSCOhost, https://doi.org/10.15761/jts.1000287.

APA

Iovino L, E. Benedetti, Giulia Cervetti, Enrico Orciuolo, M. Petrini, Nadia Cecconi, Carulli G, Matteo Pelosini, S. Galimberti, Gabriele Buda, F. Caracciolo, & F. Mazziotta. (2018). Recurrence of a 30-years old leukemic clone ten years after allogeneic transplant: Azacitidine and donor lymphocyte infusion are an effective strategy to restore the graft-versus leukemia effect. Journal of Translational Science, 5. https://doi.org/10.15761/jts.1000287

Chicago

Iovino L, E. Benedetti, Giulia Cervetti, Enrico Orciuolo, M. Petrini, Nadia Cecconi, Carulli G, et al. 2018. “Recurrence of a 30-Years Old Leukemic Clone Ten Years after Allogeneic Transplant: Azacitidine and Donor Lymphocyte Infusion Are an Effective Strategy to Restore the Graft-versus Leukemia Effect.” Journal of Translational Science 5 (January). doi:10.15761/jts.1000287.